Definium Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DFTX | ATAI | DNTH | ACAD | PRAX | PTCT | |
|---|---|---|---|---|---|---|
| Market cap | 4.39B | — | 4.80B | 3.70B | 7.95B | 5.76B |
| P/E (TTM) | — | — | — | 9.6 | — | — |
| Forward P/E | -16.9 | — | -18.6 | 23.3 | -30.0 | 28.4 |
| Price/book | 4.8 | — | 7.5 | 3.0 | 5.9 | -30.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +188.36% | — | +135.55% | −7.88% | +70.38% | −5.09% |
| Today | −2.13% | 0.00% | +3.76% | +4.38% | +1.53% | +1.25% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DFTX news ›Definium Therapeutics Announces New Employee Inducement Grants
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP) Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers…
Analysts’ Top Healthcare Picks: ArriVent BioPharma, Inc. (AVBP), Definium Therapeutics (DFTX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ArriVent BioPharma, Inc. (AVBP), Definium Therapeutics (DFTX) and Rocket Pharmaceuticals (RCKT) with bullish sentiments. ArriVent BioPharma,…
DexCom officer Michael Jon Brown sells 1,700 shares
At $85.48 a share, DexCom (DXCM) officer Michael Jon Brown sells 1,700 shares. Stock Titan DexCom officer Michael Jon Brown sells 1,700 shares The reported post-sale direct position includes 71,903 unvested restricted stock units.…
Intapp product chief Thad Jampol sells 5,000 shares
Under a prearranged plan, Intapp (INTA) product chief sells 5,000 shares. Stock Titan Intapp product chief Thad Jampol sells 5,000 shares The chief product officer's reported trades ranged from $40.00 to $40.58 on October 13 and from…
CMPS Stock Jumps Overnight After Trump Order Fast-Tracks Psychedelic Therapies
Compass Pathways (CMPS) stock gained overnight on Sunday as the company voiced support for the White House’s executive action to speed up research, approval, and availability of psychedelic-based treatments. The company specializes in…
DEFINITY CHIEF EXECUTIVE OFFICER ROWAN SAUNDERS TO PARTICIPATE IN FIRESIDE CHAT AT 25TH ANNUAL CIBC EASTERN INSTITUTIONAL INVESTOR CONFERENCE
Sep 22, 2026, 08:00 ET WATERLOO, ON, Sept. 22, 2026 /CNW/ -- Rowan Saunders, President and Chief Executive Officer of Definity Financial Corporation (TSX: DFY), will participate in a fireside chat as part of the 25th Annual CIBC Eastern…
Lifeway Foods: Divisadero buys 103,684 shares
SEC Form 4 insider trading data for Divisadero Street Capital Management, LP, Divisadero Street Partners GP, LLC, Zolezzi William, Divisadero Street Partners, L.P., Divisadero Street Capital, LLC at Lifeway Foods, Inc. - [Form 4] Lifeway…
Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
Dianthus Therapeutics (Nasdaq: DNTH) was selected for Fortune’s 2026 Best Workplaces in BioPharma list, marking its first appearance on the list. It ranked among the top 30 small- and medium-sized biotechnology and pharmaceutical companies…
Artiva Biotherapeutics medical chief sells 1,099 shares
Artiva Biotherapeutics (Nasdaq: ARTV) is a clinical-stage biotech developing NK cell therapies, led by AlloNK for B-cell driven autoimmune diseases and cancers. - [Form 4] Artiva Biotherapeutics, Inc. Insider Trading Activity Artiva…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net7
- markets.businessinsider.com1
- newswire.ca1
- stocktwits.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.